ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 126 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,746,699 | -18.6% | 582,233 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $2,146,607 | +21.7% | 573,959 | +9.0% | 0.00% | 0.0% |
| Q1 2023 | $1,763,269 | -35.1% | 526,349 | -6.8% | 0.00% | 0.0% |
| Q4 2022 | $2,715,216 | -13.8% | 564,494 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $3,149,000 | +3.7% | 553,324 | +29.4% | 0.00% | 0.0% |
| Q2 2022 | $3,037,000 | +1.4% | 427,721 | +3.2% | 0.00% | 0.0% |
| Q1 2022 | $2,994,000 | -15.3% | 414,597 | +4.9% | 0.00% | 0.0% |
| Q4 2021 | $3,534,000 | -74.4% | 395,247 | +0.5% | 0.00% | -80.0% |
| Q3 2021 | $13,785,000 | +226.8% | 393,179 | +100.3% | 0.01% | +400.0% |
| Q2 2021 | $4,218,000 | -23.1% | 196,339 | +121.0% | 0.00% | -50.0% |
| Q1 2021 | $5,486,000 | +51.9% | 88,840 | +2.8% | 0.00% | +100.0% |
| Q4 2020 | $3,612,000 | – | 86,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |